XPH
State Street SPDR S&P Pharmaceuticals ETF
Price Chart
Latest Quote
$63.96
+1.06 (+1.69%)
Current Price
| Previous Close | $62.90 |
| Open | $62.89 |
| Day High | $63.96 |
| Day Low | $62.79 |
| Volume | 50,931 |
Fund Information
| Quarterly Dividend / Yield | N/A / 0.42% |
| Net Assets | $523.98M |
| Expense Ratio | 0.35% |
| Category | Health |
| Fund Family | State Street Investment Management |
| Net Asset Value | $62.92 |
| Premium/Discount | 1.66% |
| Quarterly Dividend Yield | 0.42% |
| Exchange | PCX |
đ ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $63.37 |
| SMA50 | $67.08 |
| SMA200 | $61.53 |
| RSI | 54.34 |
| ATR | 1.3686 |
| Rel Volume | 0.26 |
Performance History
| Week | -0.30% |
| Month | -4.38% |
| Quarter | -6.84% |
| 6 Months | +11.70% |
| YTD | +16.17% |
| Year | +31.91% |
| 3 Years | +80.04% |
| 5 Years | +42.37% |
| 10 Years | +73.79% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-10-27 | $63.96 | 50,900 |
| 2026-10-26 | $62.90 | 44,800 |
| 2026-10-23 | $62.70 | 39,800 |
| 2026-10-22 | $64.28 | 141,900 |
| 2026-10-21 | $63.96 | 105,400 |
| 2026-10-20 | $64.15 | 156,600 |
| 2026-10-19 | $62.24 | 59,600 |
| 2026-10-16 | $61.84 | 241,500 |
| 2026-10-15 | $63.02 | 137,700 |
| 2026-10-14 | $62.07 | 109,800 |
| 2026-10-13 | $62.10 | 75,700 |
| 2026-10-12 | $64.01 | 234,600 |
| 2026-10-09 | $64.65 | 82,500 |
| 2026-10-08 | $63.63 | 188,100 |
| 2026-10-07 | $62.91 | 252,200 |
| 2026-10-06 | $62.91 | 534,000 |
| 2026-10-05 | $63.66 | 427,100 |
| 2026-10-02 | $63.64 | 312,500 |
| 2026-10-01 | $63.78 | 589,500 |
| 2026-09-30 | $65.00 | 137,500 |
| 2026-09-29 | $66.09 | 155,100 |
| 2026-09-28 | $66.89 | 278,300 |
About State Street SPDR S&P Pharmaceuticals ETF
In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals segment of the S&P Total Market Index ("S&P TMI").
đ° Latest News
No news articles available at the moment. Check back later for updates on XPH.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.